Timing of Thyroxine Dose In Ramadan
NCT05421468 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 250
Last updated 2022-06-16
Summary
A Randomized trial comparing two different timing of taking thyroxine in patients with Hypothyroidism during fasting the month of Ramadan.
Conditions
Interventions
- OTHER
-
L-Thyroxine time B (5-15 minutes Before dawn)
Taking thyroxine at two different time points in relation to fasting and food intake; just before dawn and start of fast compared to the usual timing of 30-60minutes after the sunset breakfast meal.
Sponsors & Collaborators
-
King Abdullah International Medical Research Center
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-03-14
- Primary Completion
- 2022-08-30
- Completion
- 2022-10-30
Countries
- Saudi Arabia
Study Locations
More Related Trials
-
Iodine Supplementation in Graves' Hyperthyroidism
NCT06540469 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Assessing the Impact of the Early and Systematic Hormonal Replacement After Radio-isotopic Ablation of Graves'hyperthyroïdism on Quality of Life, Efficiency and Tolerance
NCT01295333 ·Status: COMPLETED ·Phase: PHASE3
-
Thyroid Replacement Therapy in Patients With Subclinical Hypothyroidism
NCT04953195 ·Status: UNKNOWN ·Phase: PHASE4
-
Study of Radioiodine (131-I) Uptake Following Administration of Thyrogen and Hypothyroid States During Thyroid Hormone Withdrawal.
NCT00001730 ·Status: COMPLETED ·Phase: PHASE4
-
Discontinuation of Levothyroxine Therapy for Patients With Subclinical Hypothyroidism
NCT04288115 ·Status: COMPLETED ·Phase: PHASE4
-
Levothyroxine Treatment for Subclinical Hypothyroidism After Head and Neck Surgery
NCT02548715 ·Status: WITHDRAWN ·Phase: PHASE2/PHASE3
-
Hypothyroidism, Metabolism and Food Intake
NCT02993562 ·Status: COMPLETED
-
Thyroxin Treatment in Sub Clinical Hypothyroidism, on the Apnea Hypopnea Index Score, Lipids and Highly Sensitive CRP
NCT01486667 ·Status: UNKNOWN ·Phase: PHASE3
-
Antithyroid Drug Treatment of Thyrotoxicosis in Young People
NCT01436994 ·Status: COMPLETED ·Phase: PHASE3
-
Early Levothyroxine Post Radioactive Iodine
NCT01950260 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Efficacy of Low Dose Levothyroxine During Pregnancy
NCT03391154 ·Status: COMPLETED ·Phase: PHASE3
-
Individual Dosing of Levothyroxine After Thyroidectomy
NCT05240911 ·Status: UNKNOWN ·Phase: NA
-
Effect of L-Thyroxine on Lipid Profiles and Atherosclerosis in Subclinical Hypothyroidism
NCT01831869 ·Status: UNKNOWN ·Phase: PHASE4
-
A Randomized Controlled Trial of Thyroid Hormone Supplementation in Hemodialysis Patients
NCT03977207 ·Status: RECRUITING ·Phase: NA
-
The Role of Levothyroxine on Goiter With Atypia of Undetermined Significance
NCT02329379 ·Status: WITHDRAWN ·Phase: PHASE4
-
Factors Affecting Timing of Hypothyroidism Following Radioactive Iodine Therapy Patients With Graves Disease
NCT05643365 ·Status: RECRUITING
-
Levothyroxine Treatment in Thyroid Benign Nodular Goiter
NCT00552253 ·Status: COMPLETED ·Phase: NA
-
Neurocognitive and Metabolic Effects of Mild Hypothyroidism
NCT00565864 ·Status: COMPLETED ·Phase: PHASE4
-
Generic vs. Name-Brand Levothyroxine
NCT00403390 ·Status: COMPLETED ·Phase: NA
-
Effects of L-thyroxine Replacement on Serum Lipid and Atherosclerosis in Hypothyroidism
NCT01848171 ·Status: UNKNOWN ·Phase: PHASE4
-
The Effect of Levothyroxine on Arterial Stiffness and Lipid Profile in Patients With Subclinical Hypothyroidism
NCT00498238 ·Status: COMPLETED ·Phase: NA
-
Thyroxine Titration Study
NCT00111735 ·Status: UNKNOWN ·Phase: PHASE4
-
TSH Suppression During Radiotherapy on Thyroid Site to Prevent Iatrogenic Hypothyroidism in Pediatric Cancer Patients
NCT05316922 ·Status: RECRUITING ·Phase: PHASE3
-
REduction of LEvothyroxine in Adults; a SElf Controlled Study
NCT05821881 ·Status: UNKNOWN
-
Randomized Crossover Trial for the Evaluation of the Possible Effects in the Intestine of Two Different Pharmaceutical Forms of L - Thyroxine in Patients With Primary Acquired Hypothyroidism
NCT02917863 ·Status: UNKNOWN ·Phase: PHASE4